Profile data is unavailable for this security.
About the company
Formycon AG is a Germany based Company. The Company is engaged in providing biosimilar drugs and formulations. The Company focuses on treatments in ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval.
- Revenue in EUR (TTM)51.78m
- Net income in EUR-169.77m
- Incorporated2012
- Employees245.00
- LocationFormycon AGFraunhoferstrasse 15, PlaneggMARTINSRIED 82152GermanyDEU
- Phone+49 89 864667100
- Fax+49 89 864667110
- Websitehttps://www.formycon.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selvita SA | 87.55m | -677.62k | 175.78m | 434.00 | -- | 2.37 | 14.22 | 2.01 | -0.1577 | -0.1577 | 20.37 | 17.23 | 0.5983 | 8.96 | 4.97 | 398,187.40 | -0.4629 | 5.76 | -0.5715 | 7.33 | 80.27 | 80.65 | -0.7737 | 8.57 | 0.8823 | 0.7538 | 0.3757 | -- | -1.73 | -- | -108.73 | -- | -- | -- |
| Diamyd Medical AB | 32.65k | -17.12m | 180.00m | 41.00 | -- | 8.50 | -- | 5,513.88 | -1.52 | -1.52 | 0.0029 | 1.68 | 0.0013 | -- | 18.81 | 8,923.08 | -69.46 | -44.47 | -76.54 | -49.74 | -- | -- | -52,430.46 | -31,802.45 | -- | -- | 0.1628 | -- | 0.00 | -17.54 | -11.81 | -- | 38.40 | -- |
| Saniona AB | 40.75m | 26.70m | 186.19m | 34.00 | 6.90 | 3.13 | 6.81 | 4.57 | 2.08 | 2.08 | 3.32 | 4.60 | 0.8522 | -- | 44.79 | 12,776,440.00 | 55.85 | -14.54 | 65.47 | -17.31 | 78.84 | 27.41 | 65.53 | -30.17 | -- | -- | 0.00 | -- | 29.80 | 121.23 | 50.85 | -- | 71.22 | -- |
| Egetis Therapeutics AB (publ) | 5.86m | -32.14m | 207.59m | 40.00 | -- | 6.53 | -- | 35.41 | -0.9237 | -0.9237 | 0.1698 | 0.8571 | 0.0873 | 30.36 | 3.60 | 1,562,500.00 | -47.87 | -39.01 | -69.47 | -46.68 | 19.84 | 61.77 | -548.16 | -577.70 | 1.04 | -35.79 | 0.1951 | -- | 35.36 | 8.94 | 0.3201 | -- | 128.65 | -- |
| Sensorion SA | 0.00 | -28.09m | 215.25m | 68.00 | -- | 2.21 | -- | -- | -0.0931 | -0.0931 | 0.00 | 0.1895 | 0.00 | -- | -- | 0.00 | -32.12 | -34.53 | -38.36 | -43.50 | -- | -- | -- | -- | -- | -- | 0.0265 | -- | -- | -- | -17.72 | -- | 98.90 | -- |
| Transgene SA | 7.24m | -36.78m | 218.25m | 147.00 | -- | -- | -- | 30.15 | -0.1456 | -0.1456 | 0.0618 | -0.0272 | 0.1578 | -- | 8.72 | 43,872.73 | -80.19 | -33.32 | -186.71 | -40.55 | -- | -- | -508.10 | -251.37 | -- | -17.28 | 1.13 | -- | -20.34 | -14.48 | -52.15 | -- | 12.68 | -- |
| Oryzon Genomics SA | 0.00 | -2.61m | 222.09m | 44.00 | -- | 1.83 | -- | -- | -0.0381 | -0.0381 | 0.00 | 1.52 | 0.00 | 516.83 | -- | 0.00 | -2.05 | -3.45 | -2.30 | -3.94 | -- | -- | -- | -- | 1.94 | -29.95 | 0.0608 | -- | -- | -- | 27.18 | -- | 3.55 | -- |
| Eurobio Scientific SA | 162.09m | 2.36m | 230.60m | 380.00 | 95.91 | 1.25 | 12.94 | 1.42 | 0.2346 | 0.2346 | 15.76 | 18.03 | 0.5651 | 1.62 | 5.21 | 497,196.30 | 0.8231 | 14.00 | 1.02 | 17.37 | 23.69 | 51.40 | 1.46 | 20.70 | 1.25 | 1.72 | 0.0845 | 0.00 | 18.89 | 21.21 | -17.31 | 4.86 | 15.38 | -- |
| Cellectis SA | 70.94m | -30.38m | 234.66m | 224.00 | -- | 2.73 | -- | 3.31 | -0.3029 | -0.3029 | 0.7053 | 1.19 | 0.2234 | -- | 8.58 | 316,715.80 | -9.57 | -21.50 | -16.65 | -29.24 | -- | -32.79 | -42.82 | -220.86 | -- | -3.13 | 0.5013 | -- | 435.37 | 16.44 | 66.41 | -- | -21.58 | -- |
| Vicore Pharma Holding AB | 358.06k | -44.79m | 259.86m | 37.00 | -- | 2.53 | -- | 725.76 | -1.99 | -1.99 | 0.0159 | 3.89 | 0.0032 | -- | 0.2708 | 103,162.20 | -39.42 | -46.68 | -42.79 | -51.50 | -- | -- | -12,509.14 | -1,362.60 | -- | -18.03 | -- | -- | -96.51 | -- | -183.14 | -- | -- | -- |
| Hansa Biopharma AB | 20.85m | -49.65m | 280.08m | 125.00 | -- | -- | -- | 13.43 | -6.44 | -6.44 | 2.73 | -0.8268 | 0.226 | 19.12 | 2.24 | 1,778,120.00 | -53.80 | -57.18 | -81.36 | -73.22 | 62.41 | 60.32 | -238.12 | -464.70 | 1.92 | -- | 1.10 | -- | 29.74 | 105.28 | 34.44 | -- | -- | -- |
| Avacta Group Plc | -12.80m | -38.20m | 330.48m | 151.00 | -- | 1,777.08 | -- | -- | -0.0891 | -0.1579 | -0.0298 | 0.0004 | -0.1872 | -- | -- | -73,456.95 | -55.83 | -43.48 | -129.38 | -78.27 | -- | 63.54 | -- | -781.44 | 0.7883 | -0.4837 | 0.993 | -- | -96.04 | -- | -0.9503 | -- | -- | -- |
| Formycon AG | 51.78m | -169.77m | 338.09m | 245.00 | -- | 0.8289 | -- | 6.53 | -9.60 | -9.60 | 2.93 | 23.12 | 0.0613 | 31.72 | 1.91 | 207,112.00 | -20.09 | -1.47 | -21.17 | -1.58 | -0.9927 | 25.54 | -327.88 | -13.00 | 1.51 | -1.27 | 0.0244 | -- | -10.32 | 15.48 | -265.81 | -- | 96.87 | -- |
| Puretech Health PLC | 5.49m | 43.55m | 340.51m | 56.00 | 7.91 | 1.05 | 11.22 | 62.01 | 0.1542 | 0.1542 | 0.0197 | 1.16 | 0.0113 | -- | 2.81 | 84,945.52 | 5.63 | -3.27 | 6.57 | -3.83 | -- | -- | 498.87 | -253.25 | -- | -- | 0.0537 | -- | 44.98 | -13.21 | 181.45 | -33.81 | -75.53 | -- |
| Newron Pharmaceuticals SpA | 60.06m | 25.40m | 405.70m | 22.00 | 14.28 | 245.85 | 15.86 | 6.75 | 1.23 | 1.23 | 2.81 | 0.0717 | 1.39 | -- | 11.69 | 2,461,206.00 | 58.67 | -23.70 | 123.93 | -32.05 | 98.17 | 97.14 | 42.30 | -69.33 | -- | 8.56 | 0.9708 | -- | 467.41 | 48.83 | 197.65 | -- | -23.92 | -- |
| Genfit SA | 45.41m | -38.76m | 445.08m | 188.00 | -- | 8.48 | -- | 9.80 | -0.7737 | -0.7737 | 0.9083 | 1.05 | 0.2207 | 519.75 | 0.9236 | 252,277.80 | -18.84 | -7.73 | -23.25 | -9.79 | 95.42 | 95.68 | -85.35 | -37.15 | 3.74 | -10.87 | 0.1223 | -- | 85.82 | 11.61 | 105.22 | -- | -13.57 | -- |
Data as of Mar 09 2026. Currency figures normalised to Formycon AG's reporting currency: Euro EUR
7.14%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Active Ownership Corp SARLas of 30 Jun 2025 | 1.07m | 6.04% |
| American Century Investment Management, Inc.as of 05 Feb 2026 | 44.76k | 0.25% |
| Paladin Asset Management Investmentaktiengesellschaft TGVas of 30 Jun 2025 | 43.88k | 0.25% |
| GS&P Kapitalanlagegesellschaft SAas of 30 Jun 2025 | 32.50k | 0.18% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 29 Aug 2025 | 26.00k | 0.15% |
| Proaktiva GmbHas of 30 Dec 2025 | 16.00k | 0.09% |
| HANSAINVEST Hanseatische Investment-GmbHas of 31 Dec 2025 | 11.55k | 0.07% |
| NFS Netfonds Financial Service GmbHas of 31 Dec 2025 | 9.58k | 0.05% |
| Spirit Asset Management SAas of 30 Jun 2025 | 5.25k | 0.03% |
| Goyer & G�ppel KGas of 30 Jan 2026 | 5.00k | 0.03% |
More ▼
Data from 30 Jun 2025 - 10 Feb 2026Source: FactSet Research Systems Inc.
